Zobrazeno 1 - 10 of 36 pro vyhledávání: '"Nausea/chemically induced"'
1
Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials
Autor: Katarzyna Nabrdalik, Karolina Skonieczna-Żydecka, Krzysztof Irlik, Mirela Hendel, Hanna Kwiendacz, Igor Łoniewski, Kornelia Januszkiewicz, Janusz Gumprecht, Gregory Y. H. Lip
Publikováno v: Nabrdalik, K, Skonieczna-Żydecka, K, Irlik, K, Hendel, M, Kwiendacz, H, Łoniewski, I, Januszkiewicz, K, Gumprecht, J & Lip, G Y H 2022, ' Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus : A systematic review, meta-analysis and meta-regression of randomized controlled trials ', Frontiers in Endocrinology, vol. 13, 975912 . https://doi.org/10.3389/fendo.2022.975912
IntroductionMetformin is the first choice drug in the treatment of type 2 diabetes mellitus but its administration may be linked to gastrointestinal adverse events limiting its use.ObjectivesThe objective of this systematic review and meta-analysis w
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8111c19d299579df5560c9fb6516f817
Zobrazit plný text záznamu
2
Peripheral N-methyl-d-aspartate receptor activation contributes to monosodium glutamate-induced headache but not nausea behaviours in rats
Autor: Tarique Benbow, Felisha Teja, Afrooz Sheikhi, Fernando G. Exposto, Peter Svensson, Brian E. Cairns
Publikováno v: Benbow, T, Teja, F, Sheikhi, A, Exposto, F G, Svensson, P & Cairns, B E 2022, ' Peripheral N-methyl-D-aspartate receptor activation contributes to monosodium glutamate-induced headache but not nausea behaviours in rats ', Scientific Reports, vol. 12, 13894 . https://doi.org/10.1038/s41598-022-18290-w
Monosodium glutamate induces behaviors thought to reflect headache and nausea in rats. We explored the effects of the N-methyl-d-aspartate receptor antagonist (2R)-amino-5-phosphonovaleric acid, the inotropic glutamate receptor antagonist kynurenic a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a217357c44947d55d959783fecebd03
https://doi.org/10.1038/s41598-022-18290-w
Zobrazit plný text záznamu
3
Prolonged lipopolysaccharide-induced illness elevates glucagon-like peptide-1 and suppresses peptide YY: A human-randomized cross-over trial
Autor: Katrine Brodersen, Maike Mose, Ulla Ramer Mikkelsen, Jens Otto Lunde Jørgensen, Michael Festersen Nielsen, Niels Møller, Anne‐Marie Wegeberg, Christina Brock, Bolette Hartmann, Jens Juul Holst, Nikolaj Rittig
Publikováno v: Brodersen, K, Mose, M, Ramer Mikkelsen, U, Jørgensen, J O L, Festersen Nielsen, M, Møller, N, Wegeberg, A-M, Brock, C, Hartmann, B, Holst, J J & Rittig, N 2022, ' Prolonged lipopolysaccharide-induced illness elevates glucagon-like peptide-1 and suppresses peptide YY : A human-randomized cross-over trial ', Physiological Reports, vol. 10, no. 18, e15462 . https://doi.org/10.14814/phy2.15462
Severe systemic inflammation is associated with nausea, loss of appetite, and delayed gastric emptying, which increases hospitalization admission length and mortality rate. There is a lack of human controlled studies exploring gastric emptying rates
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e4c8b34b424f0ff3278364f097028f8
https://pubmed.ncbi.nlm.nih.gov/36117310
Zobrazit plný text záznamu
4
Cannabinoid hyperemesis-syndrom kan lindres af varme bade
Autor: Søndermølle, Maria Birgitte, Randers, Else
Publikováno v: Søndermølle, M B & Randers, E 2021, ' Cannabinoid hyperemesis-syndrom kan lindres af varme bade ', Ugeskrift for Læger, bind 183, nr. 15, V12200914 . < https://ugeskriftet.dk/videnskab/cannabinoid-hyperemesis-syndrom-kan-lindres-af-varme-bade >
This is a case report of a 19-year-old woman with cannabinoid hyperemesis syndrome (CHS), which is characterised by cyclic vomiting and nausea, relieved by hot showers and caused by chronic cannabis usage. Many diagnoses must be ruled out, but the su
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::08d1c4db470eb3dc5decab923ba3065f
https://pure.au.dk/portal/da/publications/cannabinoid-hyperemesissyndrom-kan-lindres-af-varme-bade(5a437ea5-cb6d-4eeb-96a6-e145a76ba98d).html
Zobrazit plný text záznamu
5
Administration précoce de témozolomide après chirurgie chez des patients ayant un glioblastome de mauvais pronostic : étude de faisabilité
Autor: Niloufar Sadeghi, Elly Chaskis, Daniel Devriendt, Serge Goldman, Olivier De Witte, Christian Melot, Florence Lefranc, Sylvie Luce
Publikováno v: Bulletin du cancer, 105 (7-8
Introduction: Despite the combined adjuvant treatment of radiotherapy plus chemotherapy with temozolomide (TMZ) followed by 6 cycles of temozolomide after surgery, the prognosis of patients with glioblastoma remains poor. We conducted a monocentric p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f705df8606d4d5e07ec2cc8b8835e351
https://doi.org/10.1016/j.bulcan.2018.05.006
Zobrazit plný text záznamu
6
Amisulpride in the prevention of nausea and vomiting induced by cisplatin-based chemotherapy: a dose-escalation study
Autor: Alex Molassiotis, Paul D. Taylor, Gedske Daugaard, Karin Holmskov, Jørn Herrstedt, Gabriel M. Fox, T.B. Christensen, Yvonne Summers
Publikováno v: Herrstedt, J, Summers, Y, Daugaard, G, Christensen, T B, Holmskov, K, Taylor, P D, Fox, G M & Molassiotis, A 2018, ' Amisulpride in the prevention of nausea and vomiting induced by cisplatin-based chemotherapy : a dose-escalation study ', Supportive Care in Cancer, vol. 26, no. 1, pp. 139–145 . https://doi.org/10.1007/s00520-017-3825-2
Purpose: The purpose of this study was to investigate the antiemetic effect of the dopamine D2- and dopamine D3-receptor antagonist, amisulpride, in patients receiving cisplatin-based chemotherapy. Methods: This dose-finding, non-comparative study in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f991df6196bad9c630c28fd549d1f568
https://doi.org/10.1007/s00520-017-3825-2
Zobrazit plný text záznamu
7
Adverse events in people taking macrolide antibiotics versus placebo for any indication
Autor: Jeffrey K Aronson, Malene Plejdrup Hansen, Anna Mae Scott, Elaine Beller, Justin Clark, Chris Del Mar, Paul Glasziou, Sarah Thorning, Amanda McCullough, Tammy Hoffmann
Publikováno v: The Cochrane Library
Hansen, M P, Scott, A M, McCullough, A, Thorning, S, Aronson, J K, Beller, E M, Glasziou, P P, Hoffmann, T C, Clark, J & Mar, C B D 2019, ' Adverse events in people taking macrolide antibiotics versus placebo for any indication ', Cochrane Database of Systematic Reviews, vol. 2019, no. 1, CD011825 . https://doi.org/10.1002/14651858.CD011825.pub2
BACKGROUND: Macrolide antibiotics (macrolides) are among the most commonly prescribed antibiotics worldwide and are used for a wide range of infections. However, macrolides also expose people to the risk of adverse events. The current understanding o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e77a101af5840b70d073cf8754163a9
http://ora.ox.ac.uk/objects/uuid:
Zobrazit plný text záznamu
8
Niraparib in patients with newly diagnosed advanced ovarian cancer
Autor: Kaiming Sun, Mansoor Raza Mirza, Gog Investigators, Whitney Graybill, C McCormick, Engot-Ov, Paul Hoskins, K. Jardon, Ilan Bruchim, Bhavana Pothuri, Giorgia Mangili, Pilar Barretina-Ginesta, Y. Li, Mark S. Shahin, Ashley Haggerty, Ignace Vergote, Klaus Baumann, Domenica Lorusso, William H. Bradley, Bente Lund, Gilles Freyer, Floor J. Backes, René dePont Christensen, Divya Gupta, Antonio González-Martín, Christof Vulsteke, Roisin E. O'Cearbhaill, Andrés Redondo, Bradley J. Monk, I Malinowska, Maria J. Rubio-Pérez, Richard G. Moore
Publikováno v: NEW ENGLAND JOURNAL OF MEDICINE
The New England journal of medicine
González-Martín, A, Pothuri, B, Vergote, I, DePont Christensen, R, Graybill, W, Mirza, M R, McCormick, C, Lorusso, D, Hoskins, P, Freyer, G, Baumann, K, Jardon, K, Redondo, A, Moore, R G, Vulsteke, C, O'Cearbhaill, R E, Lund, B, Backes, F, Barretina-Ginesta, P, Haggerty, A F, Rubio-Pérez, M J, Shahin, M S, Mangili, G, Bradley, W H, Bruchim, I, Sun, K, Malinowska, I A, Li, Y, Gupta, D, Monk, B J & PRIMA/ENGOT-OV26/GOG-3012 Investigators 2019, ' Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer ', The New England Journal of Medicine, vol. 381, no. 25, pp. 2391-2402 . https://doi.org/10.1056/NEJMoa1910962
González-Martín, A, Pothuri, B, Vergote, I, Christensen, R D P, Graybill, W, Mirza, M R, Mccormick, C, Lorusso, D, Hoskins, P, Freyer, G, Baumann, K, Jardon, K, Redondo, A, Moore, R G, Vulsteke, C, O'cearbhaill, R E, Lund, B, Backes, F, Barretina-Ginesta, P, Haggerty, A F, Rubio-Pérez, M J, Shahin, M S, Mangili, G, Bradley, W H, Bruchim, I, Sun, K, Malinowska, I A, Li, Y, Gupta, D & Monk, B J 2020, ' Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer ', Obstetrical and Gynecological Survey, vol. 75, no. 1, pp. 29-31 . https://doi.org/10.1097/OGX.0000000000000756
BACKGROUND: Niraparib, an inhibitor of poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP), has been associated with significantly increased progression-free survival among patients with recurrent ovarian cancer after platinum-based chemothera
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1534e2870211af93c2463e93befee7dc
https://hdl.handle.net/1854/LU-8656555
Zobrazit plný text záznamu
9
Insufficient evidence in prophylactic therapy of chemotherapy-induced nausea and vomiting in children and adolescents
Autor: Eliasen, Astrid, Callesen, Michael Thude, Dalhoff, Kim Peder, Rechnitzer, Catherine, Schmiegelow, Kjeld, Schrøder, Henrik, Tuckuviene, Ruta, Holst, Helle
Publikováno v: Eliasen, A, Callesen, M, Dalhoff, K P, Rechnitzer, C, Schmiegelow, K, Schrøder, H, Tuckuviene, R & Holst, H 2019, ' Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge ', Ugeskrift for Laeger, bind 181, nr. 9, V11170851 . < http://ugeskriftet.dk/videnskab/manglende-evidens-i-forebyggelse-af-kemoterapiinduceret-kvalme-og-opkastning-hos-boern-og >
Eliasen, A, Callesen, M T, Dalhoff, K P, Rechnitzer, C, Schmiegelow, K, Schrøder, H, Tuckuviene, R & Holst, H 2018, ' Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge ', Ugeskrift for Laeger, bind 180, V11170851, s. 1-7 . < http://ugeskriftet.dk/videnskab/manglende-evidens-i-forebyggelse-af-kemoterapiinduceret-kvalme-og-opkastning-hos-boern-og >
Eliasen, A, Callesen, M T, Dalhoff, K P, Rechnitzer, C, Schmiegelow, K, Schrøder, H, Tuckuviene, R & Holst, H 2018, ' Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge ', Ugeskrift for Laeger, bind 180, nr. 35, V11170851 .
Nausea and vomiting are burdensome side effects of chemotherapy. Vomiting is observed in up to 60% of treated children. An appropriate and effective antiemetic regimen has the potential to eradicate or reduce the symptoms. Differences in local guidel
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::01d42cac7fe3821d6756bbd06ce05de2
http://ugeskriftet.dk/videnskab/manglende-evidens-i-forebyggelse-af-kemoterapiinduceret-kvalme-og-opkastning-hos-boern-og
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje